MCC950 Ameliorates Acute Exogenous Lipoid Pneumonia Induced by Sewing Machine Oil in Rats via the NF-κB/NLRP3

Wan-Ding Ye1, Hua-Min Wang1, Zi-Jin Xu2

  • 1Department of Pediatrics, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, P.R. China.

In Vivo (Athens, Greece)
|October 31, 2023
PubMed
Abstract

Insights

MCC950 treatment reduced inflammation in rats with acute exogenous lipoid pneumonia (AELP) induced by sewing machine oil. This study shows MCC950 inhibits the NF-κB/NLRP3 inflammasome pathway, offering a potential therapeutic strategy for AELP.

Area of Science:

  • Pulmonary Medicine
  • Toxicology
  • Pharmacology

Background:

  • Acute exogenous lipoid pneumonia (AELP) is a rare, underdiagnosed condition resulting from lipid formulation intake.
  • The precise mechanisms underlying AELP pathogenesis remain unclear.
  • MCC950 is known to inhibit inflammatory cytokines IL-18 and IL-1β, but its effect on sewing machine oil-induced AELP was uninvestigated.

Purpose of the Study:

  • To investigate the therapeutic effect of MCC950 on sewing machine oil-induced AELP in a rat model.
  • To elucidate the underlying molecular mechanisms, particularly the involvement of the NF-κB/NLRP3 inflammasome pathway.

Main Methods:

  • A rat model of AELP was established using sewing machine oil.
  • Western blotting and real-time quantitative assays were used to measure NLRP3, NF-κB p65, caspase-1, and IL-1β expression.
  • Hematoxylin and eosin (H&E) staining was performed to assess inflammatory cell infiltration.

Main Results:

  • MCC950 treatment significantly reduced NF-κB p65 expression in lung tissues.
  • MCC950 down-regulated NLRP3 and caspase-1 levels and inhibited IL-1β production.
  • H&E staining revealed decreased inflammatory cell infiltration in the lungs of MCC950-treated rats.

Conclusions:

  • MCC950 effectively ameliorates sewing machine oil-induced AELP in rats.
  • The therapeutic effect is mediated by the inhibition of the NF-κB/NLRP3 inflammasome pathway.
  • This study highlights MCC950 as a potential therapeutic agent for AELP.

Related Concept Videos